Institutions / Deerfield Management Company, L.P. / Activity
Activity — Deerfield Management Company, L.P.
78 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Exit | Doximity, Inc. Common stock | $-2.30M | -52K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Davita Inc. Common stock | $-2.38M | -21K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Boston Scientific Corp Common stock | $-2.38M | -25K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Resmed Inc Common stock | $-2.43M | -10K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Trupanion, Inc. Common stock | $-2.48M | -66K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Cigna Group Common stock | $-2.53M | -9K -100.00% | 0 | low |
| Q1 2026 as of | Exit | KIDS Orthopediatrics Corp Common Stock | $-2.56M | -144K -100.00% | 0 | low |
| Q1 2026 as of | Exit | WOOF Petco Health & Wellness Company, Inc. Common Stock | $-2.63M | -936K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Chemed Corp Common stock | $-2.66M | -6K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Biolife Solutions Inc Common stock | $-2.91M | -120K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Insulet Corp Common stock | $-3.02M | -11K -100.00% | 0 | low |
| Q1 2026 as of | Exit | TransMedics Group, Inc. Common stock | $-3.10M | -25K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Quest Diagnostics Inc Common stock | $-3.19M | -18K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Alignment Healthcare, Inc. Common stock | $-3.25M | -164K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Enovis CORP Common stock | $-3.39M | -127K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Labcorp Holdings Inc. Common stock | $-3.47M | -14K -100.00% | 0 | low |
| Q1 2026 as of | Exit | RadNet, Inc. Common stock | $-3.56M | -50K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Veeva Systems Inc Common stock | $-3.95M | -18K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Prestige Consumer Healthcare Inc Common stock | $-4.30M | -70K -100.00% | 0 | low |
| Q1 2026 as of | Exit | CALC CalciMedica, Inc. Common Stock | $-8.57M | -1.3M -100.00% | 0 | medium |
| Q1 2026 as of | Exit | OMDA Omada Health, Inc. Common Stock | $-8.73M | -553K -100.00% | 0 | medium |
| Q1 2026 as of | Exit | Medline Inc. Common stock | $-10.92M | -260K -100.00% | 0 | medium |
| Q1 2026 as of | Exit | CorMedix Inc. Common stock | $-12.89M | -1.1M -100.00% | 0 | medium |
| Q1 2026 as of | Exit | Edgewise Therapeutics, Inc. Common stock | $-19.00M | -766K -100.00% | 0 | medium |
| Q1 2026 as of | Exit | Spyre Therapeutics, Inc. Common stock | $-23.28M | -711K -100.00% | 0 | medium |
| Q1 2026 as of | Exit | Ventas, Inc. Common stock | $-27.39M | -354K -100.00% | 0 | medium |
| Q1 2026 as of | Exit | Phreesia, Inc. Common stock | $-33.82M | -2.0M -100.00% | 0 | medium |
| Q1 2026 as of | Exit | G4766E116 Common stock | $-121.74M | -3.4M -100.00% | 0 | high |